MetaVia shares surge 66.95% after-hours after announcing 1-for-11 reverse stock split to comply with Nasdaq listing requirements.

MetaVia Inc. surged 66.95% in after-hours trading following the announcement of a 1-for-11 reverse stock split to comply with Nasdaq's listing requirements. The move, approved by shareholders in June 2025, reduces outstanding shares from ~25.4 million to ~2.3 million while maintaining authorized shares at 100 million. This strategic action aims to elevate the stock price above Nasdaq's minimum bid price threshold, avoid delisting, and enhance market perception. The reverse split, effective December 4, 2025, also adjusts stock option and warrant terms and addresses fractional shares with cash compensation, signaling operational stability and regulatory compliance. The announcement aligns with broader biotech sector trends of using reverse splits to sustain exchange listings and attract investment.